These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19737543)

  • 1. Inhibition of PDE3, PDE4 and PDE7 potentiates glucocorticoid-induced apoptosis and overcomes glucocorticoid resistance in CEM T leukemic cells.
    Dong H; Zitt C; Auriga C; Hatzelmann A; Epstein PM
    Biochem Pharmacol; 2010 Feb; 79(3):321-9. PubMed ID: 19737543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
    Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
    Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
    Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
    Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.
    Zhu Y; Yao J; Meng Y; Kasai A; Hiramatsu N; Hayakawa K; Miida T; Takeda M; Okada M; Kitamura M
    Br J Pharmacol; 2006 Jul; 148(6):833-44. PubMed ID: 16751794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC inhibitors induce apoptosis in glucocorticoid-resistant acute lymphatic leukemia cells despite a switch from the extrinsic to the intrinsic death pathway.
    Tsapis M; Lieb M; Manzo F; Shankaranarayanan P; Herbrecht R; Lutz P; Gronemeyer H
    Int J Biochem Cell Biol; 2007; 39(7-8):1500-9. PubMed ID: 17499001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Biochem Pharmacol; 2005 Jan; 69(2):267-75. PubMed ID: 15627479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
    Geley S; Hartmann BL; Hala M; Strasser-Wozak EM; Kapelari K; Kofler R
    Cancer Res; 1996 Nov; 56(21):5033-8. PubMed ID: 8895760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
    Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
    Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phosphodiesterase antagonists on glucocorticoid mediated growth inhibition in murine skin cell lines.
    Kowalczyk P; Kinjo T; Kowalczyk M; Walaszek Z; Hanausek M; Slaga TJ
    Eur J Pharmacol; 2009 May; 610(1-3):29-36. PubMed ID: 19306867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia.
    Zhang L; Murray F; Zahno A; Kanter JR; Chou D; Suda R; Fenlon M; Rassenti L; Cottam H; Kipps TJ; Insel PA
    Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19532-7. PubMed ID: 19033455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASB16165, a novel inhibitor for phosphodiesterase 7A (PDE7A), suppresses IL-12-induced IFN-gamma production by mouse activated T lymphocytes.
    Kadoshima-Yamaoka K; Murakawa M; Goto M; Tanaka Y; Inoue H; Murafuji H; Nagahira A; Hayashi Y; Nagahira K; Miura K; Nakatsuka T; Chamoto K; Fukuda Y; Nishimura T
    Immunol Lett; 2009 Feb; 122(2):193-7. PubMed ID: 19195485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase 4 inhibitors augment levels of glucocorticoid receptor in B cell chronic lymphocytic leukemia but not in normal circulating hematopoietic cells.
    Meyers JA; Taverna J; Chaves J; Makkinje A; Lerner A
    Clin Cancer Res; 2007 Aug; 13(16):4920-7. PubMed ID: 17699872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDE7A is expressed in human B-lymphocytes and is up-regulated by elevation of intracellular cAMP.
    Lee R; Wolda S; Moon E; Esselstyn J; Hertel C; Lerner A
    Cell Signal; 2002 Mar; 14(3):277-84. PubMed ID: 11812656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional glucocorticoid receptor expression is required for cAMP-mediated apoptosis in a human leukemic T cell line.
    Kiefer J; Okret S; Jondal M; McConkey DJ
    J Immunol; 1995 Nov; 155(10):4525-8. PubMed ID: 7594448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21(WAF1/CIP1) proteins in human acute lymphoblastic leukemia cells.
    Ogawa R; Streiff MB; Bugayenko A; Kato GJ
    Blood; 2002 May; 99(9):3390-7. PubMed ID: 11964308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of ceramide metabolism in T-leukemia cell lines potentiates apoptosis induced by the cationic antimicrobial peptide bovine lactoferricin.
    Furlong SJ; Ridgway ND; Hoskin DW
    Int J Oncol; 2008 Mar; 32(3):537-44. PubMed ID: 18292930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time monitoring of phosphodiesterase inhibition in intact cells.
    Herget S; Lohse MJ; Nikolaev VO
    Cell Signal; 2008 Aug; 20(8):1423-31. PubMed ID: 18467075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a potent and biologically-active PDE4/7 inhibitor via fission yeast-based assays.
    de Medeiros AS; Wyman AR; Alaamery MA; Allain C; Ivey FD; Wang L; Le H; Morken JP; Habara A; Le C; Cui S; Lerner A; Hoffman CS
    Cell Signal; 2017 Dec; 40():73-80. PubMed ID: 28867658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.